4
FDMT
4D Molecular Therapeutics Inc.
9.09
+0.22+2.42%Opening10:46 05/01 EDT
OPEN/PREV CLOSE8.88/8.87
TODAY RANGE8.84-9.13
VOL142.63K
MARKET CAP474.92M
52 WEEK RANGE3.000-12.34
AVG VOL (3M)757.95K
% TURNOVER0.27%
TURNOVER--
P/E (TTM)-3.7563
% RANGE3.33%
EPS(TTM)-2.4186
P/E(FORWARD)-2.5810
P/B1.035
BVPS8.78
DIVIDEND--
P/S6.14
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP458.07M
SHARES OUTSTANDING52.27M
NEXT EARNINGS05/06-05/11
FREE FLOAT50.42M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Barchart·04/17 15:05
4DMT Announces New Employment Inducement Grants
TipRanks·04/13 13:56
4D Molecular price target lowered to $23 from $45 at Evercore ISI
TipRanks·03/31 00:08
4D Molecular Therapeutics Consolidates Financial Leadership Under New Role
Dow Jones·03/30 16:10
4D Molecular Therapeutics Coverage Assumed by Jefferies at Buy
Dow Jones·03/30 16:10
4D Molecular Therapeutics Price Target Cut to $21.00/Share From $40.00 by Jefferies
TipRanks·03/30 13:08
4D Molecular assumed with a Buy at Jefferies
TipRanks·03/20 12:04
Goldman Sachs Sticks to Their Buy Rating for 4D Molecular Therapeutics (FDMT)
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.